EVIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | 0.00% |
| 2022 | DigiPath, Inc. cancelled the acquisition of a controlling stake in C3 Labs, LLC from EVIO, Inc.. | CI |
| 2022 | EVIO, Inc. Announces Partnership with Rare Earth Genomics Texas, LLC | CI |
Valuation
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 13.57 | 8.476 | 20.5 | 11.58 | 1.058 | 2.801 |
| Enterprise Value (EV) 1 | 15.06 | 12.79 | 27.32 | 23.82 | 15.85 | 15.46 |
| P/E ratio | -3.55 x | -2.24 x | -1.28 x | -0.58 x | -0.08 x | -1.33 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 24.2 x | 2.81 x | 6.09 x | 3.06 x | 0.29 x | 1.19 x |
| EV / Revenue | 26.8 x | 4.23 x | 8.12 x | 6.28 x | 4.41 x | 6.54 x |
| EV / EBITDA | -21.4 x | -7.16 x | -3.67 x | -4.06 x | -4.76 x | -5.33 x |
| EV / FCF | 27.9 x | -26.6 x | 58 x | 11.3 x | 10.3 x | -3.66 x |
| FCF Yield | 3.58% | -3.76% | 1.72% | 8.86% | 9.75% | -27.3% |
| Price to Book | -24.8 x | 134 x | 10.4 x | -1.01 x | -0.04 x | -0.21 x |
| Nbr of stocks (in thousands) | 7,800 | 10,212 | 22,802 | 28,954 | 109,045 | 3,500,821 |
| Reference price 2 | 1.740 | 0.8300 | 0.8990 | 0.4000 | 0.009700 | 0.000800 |
| Announcement Date | 2/24/17 | 1/17/18 | 8/19/19 | 5/20/20 | 4/6/22 | 4/6/22 |
1USD in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.561 | 3.021 | 3.366 | 3.79 | 3.596 | 2.363 |
| EBITDA 1 | -0.7031 | -1.786 | -7.452 | -5.86 | -3.328 | -2.902 |
| EBIT 1 | -0.7925 | -2.071 | -8.176 | -7.326 | -4.216 | -3.778 |
| Operating Margin | -141.28% | -68.55% | -242.95% | -193.3% | -117.24% | -159.88% |
| Earnings before Tax (EBT) 1 | -2.552 | -3.59 | -11.94 | -20.66 | -8.466 | -1.968 |
| Net income 1 | -2.525 | -3.56 | -11.63 | -18.55 | -8.416 | -0.965 |
| Net margin | -450.16% | -117.85% | -345.68% | -489.44% | -234.04% | -40.84% |
| EPS 2 | -0.4904 | -0.3698 | -0.7030 | -0.6899 | -0.1168 | -0.000601 |
| Free Cash Flow 1 | 0.5395 | -0.4804 | 0.471 | 2.11 | 1.546 | -4.226 |
| FCF margin | 96.17% | -15.9% | 13.99% | 55.68% | 42.99% | -178.82% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/24/17 | 1/17/18 | 8/19/19 | 5/20/20 | 4/6/22 | 4/6/22 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.49 | 4.31 | 6.82 | 12.2 | 14.8 | 12.7 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -2.115 x | -2.413 x | -0.9156 x | -2.088 x | -4.444 x | -4.363 x |
| Free Cash Flow 1 | 0.54 | -0.48 | 0.47 | 2.11 | 1.55 | -4.23 |
| ROE (net income / shareholders' equity) | 4,194% | 3,955% | -573% | 525% | 60.1% | 12.8% |
| ROA (Net income/ Total Assets) | -34% | -31.6% | -50.2% | -40.3% | -32.7% | -36.2% |
| Assets 1 | 7.429 | 11.28 | 23.19 | 46.06 | 25.75 | 2.662 |
| Book Value Per Share 2 | -0.0700 | 0.0100 | 0.0900 | -0.4000 | -0.2300 | -0 |
| Cash Flow per Share 2 | 0.0100 | 0.0100 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.01 | 0.25 | 1.4 | 0.41 | 0.06 | 0.01 |
| Capex / Sales | 2.4% | 8.38% | 41.46% | 10.76% | 1.67% | 0.34% |
| Announcement Date | 2/24/17 | 1/17/18 | 8/19/19 | 5/20/20 | 4/6/22 | 4/6/22 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 19.19K | |
| 0.00% | 6.8B | |
| -12.39% | 2.88B | |
| -11.15% | 2.72B | |
| -31.21% | 1.74B | |
| +5.00% | 1.25B | |
| -7.31% | 1.06B | |
| -6.67% | 870M | |
| -4.08% | 794M | |
| -13.72% | 768M |
- Stock Market
- Equities
- EVIO Stock
- Financials EVIO, Inc.
